Avalo Therapeutics AVTX
NASDAQ AVTX
$14.99 +0.04 (+0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Interest Coverage Ratio (2014 - 2015)

Updated

Avalo Therapeutics' (AVTX) Interest Coverage Ratio was -9.92 for Q3 2015, compared with -31.62 a year earlier.

Analysis

Avalo Therapeutics (AVTX) Interest Coverage Ratio (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.41
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.28
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 7.27
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 5.22
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -42.08
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Avalo Therapeutics 653.59 Mn 653.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 -9.92
Sep 30, 2014 -31.62
API Access

Avalo Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=AVTX&period=max&api_key=YOUR_API_KEY